Safran SA (LON:0IU8)
 307.70
 -0.20 (-0.06%)
  At close: Nov 3, 2025
Safran Revenue
Safran had revenue of 14.87B EUR in the half year ending June 30, 2025, with 32.65% growth. This brings the company's revenue in the last twelve months to 29.38B, up 14.53% year-over-year. In the year 2024, Safran had annual revenue of 27.72B with 17.19% growth.
Revenue (ttm) 
 29.38B EUR
Revenue Growth 
 +14.53%
P/S Ratio 
 4.51
Revenue / Employee 
 304.77K EUR
Employees 
 96,390
Market Cap 
113.62B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 27.72B | 4.07B | 17.19% | 
| Dec 31, 2023 | 23.65B | 4.13B | 21.14% | 
| Dec 31, 2022 | 19.52B | 4.23B | 27.66% | 
| Dec 31, 2021 | 15.29B | -1.49B | -8.86% | 
| Dec 31, 2020 | 16.78B | -8.48B | -33.58% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Shell | 200.18B | 
| BP p.l.c. | 134.89B | 
| Unilever | 51.24B | 
| HSBC Holdings | 43.13B | 
| AstraZeneca | 41.24B | 
| Rio Tinto Group | 39.22B | 
| GSK plc | 32.17B | 
| Barclays | 26.03B |